Please login to the form below

Not currently logged in
Email:
Password:

tremelimumab,

This page shows the latest tremelimumab, news and features for those working in and with pharma, biotech and healthcare.

FDA clears Kyowa Kirin’s skin lymphoma therapy Poteligeo

FDA clears Kyowa Kirin’s skin lymphoma therapy Poteligeo

drug with AstraZeneca’s PD-L1 inhibitor Imfinzi (durvalumab) and experimental CTLA4 candidate tremelimumab.

Latest news

More from news
Approximately 5 fully matching, plus 42 partially matching documents found.

Latest Intelligence

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    For instance, AZ’s MYSTIC of Imfinzi and CTLA4 drug tremelimumab in lung cancer wasn’t able to impact progression-free survival and – while the company is still hoping to show

  • Pharma deals during July 2014 Pharma deals during July 2014

    tremelimumab. Existing partners Bristol-Myers Squibb (BMS) and Ono Pharmaceutical also announced that they will jointly develop and commercialise multiple immunotherapies as single and combination treatments.

  • Interview: AstraZeneca's Susan Galbraith Interview: AstraZeneca's Susan Galbraith

    2 trials for NSCLC, and tremelimumab, an anti-CTLA4 MAb in phase 2 for the rare cancer mesothelioma. “

  • Pharma deals during August 2013 Pharma deals during August 2013

    The $500m acquisition of Amplimmune marries well with Medimmune's existing commitment to cancer immunotherapy, which includes not only the anti-PD1 mAB MEDI-4736 but also tremelimumab (CLTA-4 mAB)

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics